Abstract
New research on Oncology - Testicular Cancer is the subject of a report. According to news originating from Toronto, Canada, by NewsRx correspondents, research stated, “Open retroperitoneal lymph node dissection (O-RPLND) is the accepted standard surgical approach to treat retroperitoneal nodal disease in testis cancer. Increasingly, robotic RPLND (R-RPLND) is being performed due to the potential for lower blood loss, shorter length of stay, and accelerated recovery.”